| 肝动脉化疗栓塞术治疗原发性进展性肝细胞癌新进展 |
| |
| 引用本文： | 谷涛,于经瀛. 肝动脉化疗栓塞术治疗原发性进展性肝细胞癌新进展[J]. 协和医学杂志, 2021, 12(3): 380-385. DOI: 10.3969/j.issn.1674-9081.2020.00.012 |
| |
| 作者姓名： | 谷涛 于经瀛 |
| |
| 作者单位： | 国家老年医学中心 中国医学科学院老年医学研究所 北京医院放射科，北京100730 |
| |
| 摘 要： | 肝细胞癌(hepatocellular carcinoma,HCC)是我国最常见的恶性肿瘤之一.在治疗不可切除HCC方面,肝动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)是目前应用最广泛的局部治疗方式.随着技术的发展,TACE治疗的安全性和有效性不断提高,适...
|
| 关 键 词： | 肝细胞癌 肝动脉化疗栓塞术 药物洗脱微球-肝动脉化疗栓塞术 |
| 收稿时间： | 2019-10-09 |
New Progress in the Treatment of Advanced Primary Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization |
| |
| Affiliation: | Department of Radiology, Beijing Hospital, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, National Center of Gerontology, Beijing 100730, China |
| |
| Abstract: | Hepatocellular carcinoma(HCC) is one of the most common malignant tumors in China. Transcatheter arterial chemoembolization(TACE) is currently the most widely used locoregional treatment for unresectable HCC. With the development of technology, TACE has improved in the safety and efficacy and expanded the scope of treatment indications. The aim of this article is to summarize the latest technology and future development of TACE including TACE with drug-eluting beads in the treatment of advanced primary HCC, in order to provide guidance for clinical decision-making. |
| |
| Keywords: | |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《协和医学杂志》浏览原始摘要信息 |
|
点击此处可从《协和医学杂志》下载免费的PDF全文 |
|
